DE60228484D1 - Cytotoxische mittel - Google Patents
Cytotoxische mittelInfo
- Publication number
- DE60228484D1 DE60228484D1 DE60228484T DE60228484T DE60228484D1 DE 60228484 D1 DE60228484 D1 DE 60228484D1 DE 60228484 T DE60228484 T DE 60228484T DE 60228484 T DE60228484 T DE 60228484T DE 60228484 D1 DE60228484 D1 DE 60228484D1
- Authority
- DE
- Germany
- Prior art keywords
- cytotoxic agents
- preparing compounds
- compounds
- processes
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940127089 cytotoxic agent Drugs 0.000 title 1
- 239000002254 cytotoxic agent Substances 0.000 title 1
- 231100000599 cytotoxic agent Toxicity 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101710183280 Topoisomerase Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33304001P | 2001-11-14 | 2001-11-14 | |
US33273301P | 2001-11-14 | 2001-11-14 | |
US33269801P | 2001-11-14 | 2001-11-14 | |
US33297001P | 2001-11-14 | 2001-11-14 | |
US33305101P | 2001-11-14 | 2001-11-14 | |
PCT/US2002/036604 WO2003041653A2 (en) | 2001-11-14 | 2002-11-14 | Cytotoxic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60228484D1 true DE60228484D1 (de) | 2008-10-02 |
Family
ID=27541110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60228484T Expired - Lifetime DE60228484D1 (de) | 2001-11-14 | 2002-11-14 | Cytotoxische mittel |
Country Status (7)
Country | Link |
---|---|
US (2) | US7319105B2 (de) |
EP (1) | EP1453812B1 (de) |
AT (1) | ATE405568T1 (de) |
AU (1) | AU2002352708A1 (de) |
DE (1) | DE60228484D1 (de) |
ES (1) | ES2311639T3 (de) |
WO (1) | WO2003041653A2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1453812B1 (de) | 2001-11-14 | 2008-08-20 | Rutgers, The State University | Cytotoxische mittel |
SI1465625T1 (sl) * | 2001-11-14 | 2010-06-30 | Univ Rutgers | Solubilizirani topoizomerazni strupi |
MXPA04004607A (es) * | 2001-11-14 | 2004-09-10 | Univ Rutgers | Agentes de venenos de topoisomerasa solubilizados. |
EP1453506B1 (de) * | 2001-11-14 | 2008-04-02 | Rutgers, The State University | Topoisomerase-giftmittel |
US6989387B2 (en) * | 2002-08-09 | 2006-01-24 | Rutgers, The State University Of New Jersey | Nitro and amino substituted topoisomerase agents |
AU2003268075A1 (en) * | 2002-08-09 | 2004-02-25 | Edmond J. Lavoie | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
WO2004014862A1 (en) * | 2002-08-09 | 2004-02-19 | Rutgers, The State University | Nitro and amino substituted heterocycles as topoisomerase i targeting agents |
CA2510337C (en) | 2002-11-12 | 2013-01-08 | Rutgers, The State University Of New Jersey | Topoisomerase-targeting agents |
WO2010044885A2 (en) | 2008-10-17 | 2010-04-22 | Whitehead Institute For Biomedical Research | Soluble mtor complexes and modulators thereof |
TW201038578A (en) * | 2009-01-30 | 2010-11-01 | Univ Rutgers | Methods to treat cancer |
US9562051B2 (en) | 2009-03-06 | 2017-02-07 | Rutgers, The State University Of New Jersey | Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer |
WO2010127360A1 (en) * | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
WO2010127363A1 (en) * | 2009-05-01 | 2010-11-04 | Rutgers, The State University Of New Jersey | Toposiomerase inhibitors |
WO2013154778A1 (en) | 2012-04-11 | 2013-10-17 | Dana-Farber Cancer Institute, Inc. | Host targeted inhibitors of dengue virus and other viruses |
US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
JP6520710B2 (ja) * | 2013-11-21 | 2019-05-29 | 横浜ゴム株式会社 | 空気入りタイヤ |
US10759795B2 (en) | 2016-03-15 | 2020-09-01 | Purdue Research Foundation | Aza-A-ring indenoisoquinoline topoisomerase I poisons |
EP3442979A4 (de) | 2016-04-04 | 2019-12-18 | Rutgers, the State University of New Jersey | Topoisomerasegifte |
WO2018118852A1 (en) | 2016-12-22 | 2018-06-28 | Purdue Research Foundation | Azaindenoisoquinoline compounds and uses thereof |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2981731A (en) | 1961-04-25 | Acridine derivatives | ||
US2985661A (en) | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
US2915523A (en) | 1956-12-03 | 1959-12-01 | Parke Davis & Co | Benzacridine compounds |
US3272707A (en) | 1964-07-17 | 1966-09-13 | Smith Kline French Lab | Pharmaceutical compositions and methods for their use |
CH420045A (de) | 1964-09-01 | 1967-03-15 | Ciba Geigy | Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien |
US3267107A (en) | 1964-09-17 | 1966-08-16 | American Home Prod | 3-(4'-5'-methylenedioxy-phenyl)-7, 8-dimethoxy-1, 2, 3, 4,-tetrahydroisoquinolines |
US3849561A (en) | 1964-10-20 | 1974-11-19 | S Naruto | Anti-peptic ulcer substance from corydalis tubers |
DE1670684A1 (de) | 1966-04-01 | 1970-12-03 | Hoechst Ag | Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten |
US3542782A (en) | 1967-03-15 | 1970-11-24 | Sandoz Ag | 5,6-dihydro-8h-isoquino(1,2-b)quinazolines |
JPS4942700A (de) | 1972-08-25 | 1974-04-22 | ||
US3912740A (en) | 1974-02-28 | 1975-10-14 | Us Health | Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds |
PT73763B (fr) | 1981-10-01 | 1983-10-26 | Quatrum Empresa Nacional De Qu | Procede pour la preparation de nouveaux epoxides d'alkaloides benzofenantridiniques et de compositions pharmaceutiques qui les contiennent |
US5153178A (en) | 1982-05-14 | 1992-10-06 | Maroko Peter R | Compositions and method of treatment for improving circulatory performance |
US4980344A (en) | 1982-05-14 | 1990-12-25 | Maroko Peter R | Compositions for improving circulatory performance |
US4749708A (en) | 1982-05-14 | 1988-06-07 | Maroko Peter R | Composition for improving circulatory performance |
US4761417A (en) | 1982-05-14 | 1988-08-02 | Maroko Peter R | Compounds, compositions and method of treatments for improving circulatory performance |
IE55519B1 (en) | 1982-05-14 | 1990-10-10 | Maroko Peter R | Use of a protoberberine alkaloid and composition containing same |
JPS61130289A (ja) | 1984-11-29 | 1986-06-18 | Ss Pharmaceut Co Ltd | 13−プロピルベルベリンの塩 |
FR2595356B1 (fr) | 1986-03-05 | 1991-05-24 | Pasteur Strasbourg Universite | Derives des nitro ou aminobenzyltetrahydroisoquinoleines, procedes d'obtention, compositions pharmaceutiques les contenant, proprietes pharmacologiques et applications |
US5244903A (en) | 1987-03-31 | 1993-09-14 | Research Triangle Institute | Camptothecin analogs as potent inhibitors of topoisomerase I |
SU1530628A1 (ru) | 1987-11-20 | 1989-12-23 | Ленинградский Технологический Институт Им.Ленсовета | Тригидрохлорид 2-[2-фенил-5(6)-бензимидазолил]-N-(3-диметиламинопропил)-5(6)-бензимидазолкарбоксамида в качестве флуоресцентного красител дл исследовани ДНК |
US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
US5106863A (en) | 1990-03-26 | 1992-04-21 | Ortho Pharmaceutical Corporation | Substituted imidazole and pyridine derivatives |
US5135934A (en) | 1990-07-06 | 1992-08-04 | Du Pont Merck Pharmaceutical Company | 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents |
US5126351A (en) | 1991-01-24 | 1992-06-30 | Glaxo Inc. | Antitumor compounds |
US5223506A (en) | 1991-06-04 | 1993-06-29 | Glaxo Inc. | Cyclic antitumor compounds |
US5428040A (en) | 1993-08-31 | 1995-06-27 | The Du Pont Merck Pharmaceutical Company | Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
WO1995009153A1 (fr) | 1993-09-28 | 1995-04-06 | Kyowa Hakko Kogyo Co., Ltd. | Nouveau compose tetracyclique |
BR9608476A (pt) | 1995-05-17 | 1999-08-17 | Univ Rutgers | Composto processo para inibir o crescimento de uma célula tumoral de mam¡fero e composicão terapéutica |
US5767142A (en) | 1996-03-20 | 1998-06-16 | Rutgers, The State University Of New Jersey | Trisbenzimidazoles useful as topoisomerase I inhibitors |
US5807874A (en) | 1995-05-17 | 1998-09-15 | Rutgers, The State University Of New Jersey | Trisbenzimidazoles useful as topoisomerase I inhibitors |
US5770617A (en) | 1996-03-20 | 1998-06-23 | Rutgers, The State University Of New Jersey | Terbenzimidazoles useful as antifungal agents |
PL332416A1 (en) | 1996-09-23 | 1999-09-13 | Rutgers | Substituted heterocyclic compounds as anticarcinogenic agents |
US6140328A (en) | 1997-12-12 | 2000-10-31 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
US6509344B1 (en) | 1998-10-14 | 2003-01-21 | The United States Of America As Represented By The Department Of Health And Human Services | Indenoisoquinolines as antineoplastic agents |
WO2001032631A2 (en) * | 1999-10-29 | 2001-05-10 | Rutgers, The State University Of New Jerey | Heterocyclic cytotoxic agents |
US6740650B2 (en) | 1999-10-29 | 2004-05-25 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
MXPA04004607A (es) | 2001-11-14 | 2004-09-10 | Univ Rutgers | Agentes de venenos de topoisomerasa solubilizados. |
SI1465625T1 (sl) | 2001-11-14 | 2010-06-30 | Univ Rutgers | Solubilizirani topoizomerazni strupi |
EP1453506B1 (de) | 2001-11-14 | 2008-04-02 | Rutgers, The State University | Topoisomerase-giftmittel |
EP1453812B1 (de) | 2001-11-14 | 2008-08-20 | Rutgers, The State University | Cytotoxische mittel |
US6989387B2 (en) | 2002-08-09 | 2006-01-24 | Rutgers, The State University Of New Jersey | Nitro and amino substituted topoisomerase agents |
-
2002
- 2002-11-14 EP EP02789656A patent/EP1453812B1/de not_active Expired - Lifetime
- 2002-11-14 AU AU2002352708A patent/AU2002352708A1/en not_active Abandoned
- 2002-11-14 DE DE60228484T patent/DE60228484D1/de not_active Expired - Lifetime
- 2002-11-14 WO PCT/US2002/036604 patent/WO2003041653A2/en not_active Application Discontinuation
- 2002-11-14 ES ES02789656T patent/ES2311639T3/es not_active Expired - Lifetime
- 2002-11-14 AT AT02789656T patent/ATE405568T1/de not_active IP Right Cessation
-
2004
- 2004-05-14 US US10/846,936 patent/US7319105B2/en not_active Expired - Lifetime
-
2007
- 2007-12-12 US US11/954,380 patent/US7468366B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1453812B1 (de) | 2008-08-20 |
ATE405568T1 (de) | 2008-09-15 |
US7468366B2 (en) | 2008-12-23 |
EP1453812A4 (de) | 2005-06-08 |
US20050009825A1 (en) | 2005-01-13 |
ES2311639T3 (es) | 2009-02-16 |
US20080090831A1 (en) | 2008-04-17 |
WO2003041653A2 (en) | 2003-05-22 |
EP1453812A2 (de) | 2004-09-08 |
AU2002352708A1 (en) | 2003-05-26 |
US7319105B2 (en) | 2008-01-15 |
WO2003041653A3 (en) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE405568T1 (de) | Cytotoxische mittel | |
LTPA2020503I1 (lt) | Rapamicino darinys, skirtas kasos vėžio gydymui | |
PT1200412E (pt) | Agentes anti-proliferativos de imidazole | |
CY1107074T1 (el) | Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης | |
WO2005046603A3 (en) | Pyridine compounds | |
EP1399414A4 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
SE0301700D0 (sv) | Novel compounds | |
EE200300440A (et) | Epotilooni analoogide ja kemoterapeutikumide kombinatsioon proliferatiivsete haiguste raviks | |
PL367682A1 (en) | Dolastatin 10 derivatives | |
EA200300788A1 (ru) | Производные замещенных алкиламинов и их применение | |
YU63703A (sh) | 6-supstituisani pirido-pirimidini | |
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
DK1353668T3 (da) | Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer | |
MY128924A (en) | Novel compounds | |
MXPA04004606A (es) | Venenos de topoisomerasa solubilizados. | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
WO2004098524A3 (en) | Lipid platinum complexes and methods of use thereof | |
ATE424200T1 (de) | Solubilisierte topoisomerase-gift-mittel | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
ATE390923T1 (de) | Topoisomerase-giftmittel | |
WO2005054172A3 (en) | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof | |
WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
BR0208593A (pt) | método para o tratamento de um mamìfero, composto, e, composição farmacêutica | |
SE0004827D0 (sv) | Therapeutic compounds | |
DE60111614D1 (de) | Taxan-derivate für die behandlung von krebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |